Congenital
tuberculosis in the neonates
Tuberculosis in the
newborn due to transmission of infection in utero is relatively rare. The
mother‘s genital tract is probably often the source of the infection .
Classification
of skin tuberculosis
Tuberculosis of the skin
has different clinical and pathological features depending on the patient‘s
resistance and age .
-
Patients with good
resistance
Lupus vulgaris
Scrofuloderma.
Tuberculosis verruca cutis
Tuberculids.
Exanthematous lesions
Tuberculosis miliaris disseminata
Lupus miliaris disseminatus fasciei
Papulonecrotic Tuberculids
Lichen Scrofuloderma
-
Patients with absent
or poor resistance :
Miliary tuberculosis.
Primary tuberculous complex
LUPUS
VULGARIS
This
is the most common and most variable type of cutaneous tuberculosis.
This is a destructive form of TB of the skin affecting mainly the
exposed areas of skin on the face and extremities.
Fig. 50a. Lupus
Vulgaris
Fig. 50b. Lupus
Vulgaris
Fig. 50ac. Lupus Vulgaris
CLINICAL MANIFESTATIONS
The primary skin lesions
appear as reddish brown plaques, which have a chronic course and heal
slowly in one area and progress peripherally in another. The ulcers heal
with scar tissue leading to destruction and configuration. The nodules
have an apple-jelly color and on diascopy show the distinctive apple-jelly
yellowish brown color.
Histopathology
The histopathology of
lupus vulgaris is characterized by:
-
Epitheloid cell
nodules embedded in shells of lymphocytes.
-
Tubercle bacilli are
rarely found in the section .
-
Langerhans cells are
present .
-
Central caesation may
be found in the center of the nodules.
PRIMARY
TUBERCULOUS COMPLEX
(TUBERCULUS CHANCRE)
Primary complex lesions
involve the skin and lymph nodes mainly that of infants and young children
.
The route of entry of
tubercle bacilli is the lung. The common sites involved are the face and
extremities associated with regional lymphadenopathy.
CLINICAL
FEATURES
The most common sites
involved are the face and extremities. Mucous membrane are involved in
about one third of cases.
The lesion appears as
brownish red papule that becomes later on an indurated nodule or plaque.
These lesions take few months to heal while the enlarged lymph glands
persist longer and ulcerate .
Histopathology
Marked inflammatory
response with many Polymorphonuclear leukocytes and tubercle bacilli in
the first two weeks.
Lymphocytes and
epitheloid cells appear later and replace the polymorphs.
MILIARY
TUBERCULOSIS
This type occurs usually
in infants and young children. Dissemination of the disease occurs, often
following measles and scarlet fever or other exanthomas.
CLINICAL
FEATURES
Skin manifestations are
often variable.
The lesions may appear as
generalized acute eruption of brownish red accuminate papules that may
ulcerate forming numerous minute ulcers. These ulcers are necrotic , small
, circular and covered by seropurulent exudate.
PAPULONECROTIC
TUBERCULIDS
This type of lesion
occurs mainly in young children and adults who have TB elsewhere in the
body. This is considered as an allergic reaction to tubercle bacilli.Tuberculids are probably due to the
hematogenous dissemination of tubercle bacilli in a person with a moderate
or high degree of immunity, but the underlying focus of tuberculosis may
not be clinically active at the time of the eruption, and the patient is
often in excellent health.
CLINICAL
FEATURES
The lesions appear as
small firm follicular brownish pinhead papules that occur symmetrically on
the limbs, mainly on the extensor surface, trunk and face.
Fig.51c. Papulonecrotic tuberculid (Fresh lesion)
Central necrosis of the
lesions may follow, ending with small-pitted scars.
LICHEN
SCROFLOSORUM
The lesion occurs over
the trunk mainly in children having tuberculosis of the bone or lymph
nodes.
Skin presents with firm,
flat-topped hyperkeratotic papules surmounted by pustule or tiny scales,
arranged in groups and have a very chronic course.
The lesions may undergo
spontaneous involution and may recur again.
TUBERCULOSIS
VERRUCOSUS CUTIS
This type occurs mainly
in adults and in individuals with high resistance due to external
inoculation of tubercle bacilli.
CLINICAL
FEATURES
The lesion appears mainly
on the extremities, on the dorsum of the fingers, hands, ankles and
buttocks as single hyper keratotic red dull lesion. This is characterized
by a very chronic course that may be accompanied by lymphangitis,
lymphadenitis and rarely by skin gangrene.
Fig.31d. Tuberculosis verrucosus
cutis
DIFFERENTIAL
DIAGNOSIS
ERYTHEMA
INDURATUM
(Bazin‘s Disease)
Erythema induratum is a
chronic benign vasculitis of the subcutaneous arteries and veins
accompanied by fat necrosis. Erythema induratum has been included as a
manifestation of tuberculosis of skin, which can be caused, by
Mycobacterium tuberculosis until recently where it is considered a type of
vasculitis. This was supported by the clinical response and the healing of
lesions by corticosteroids rather than by antituberculous medications.
Fig. 52 Erythema
induratum
Fig. 53. Erythema induratum |
Fig.53 Erythema induratum
|
CLINICAL
FEATURES
Soft recurrent indolent
subcutaneous nodules symmetrically distributed on both legs , mainly in
young females . The lesions tend to heal within few months and recur
again. The covering skin becomes later dusky or bluish in color with soft
center that later may show irregular excavated ulceration. The lesions are
mildly tender.
SCROFULODERMA
Scrofuloderma occurs
mainly in children and young adults on the skin over the cervical lymph
nodes or above the bony areas.
The lesion develops secondarily to
the underlying infected lymph nodes which break down and cause
stretch of the superimposed skin leading to ulceration and sinus
formation.
CLINICAL
FEATURES
The skin covering the
inflamed lymph nodes becomes indurated , purplish in color followed by
ulceration with crusty ,irregular pale granulomatous tissue ending in
scarring.
TUBERCULOSIS
CUTIS ORIFICIALIS
Young adults and children
with complete anergy are affected by this type, which is usually
accompanied by visceral TB. The lesions involve the mucous membranes of
the mouth, palate, larynx, intestinal and lung mucous membranes.
CLINICAL
FEATURES
The lesions begin with an
oval shallow crusted ulcers extending to the adjacent areas, which run a
very chronic course.
DIAGNOSIS
Several data may suggest
the diagnosis of cutaneous tuberculosis mainly:
-
Detection of tubercle
bacilli is the most reliable and confirmatory data for the diagnosis .
-
The clinical history
and physical signs.
-
The histopathology
picture
-
A positive reaction
to tuberculin test .
-
The effective
specific antituberculous therapy.
TREATMENT
OF CUTANEOUS TUBERCULOSIS
Different courses are
used for treatment of tuberculosis.More than antituberculous drug is given
to prevent bacterial resistence.The course of treatment is a long one that
may take several months.
-
Isoniazid
Children‘s dose 8mg/kg daily , 450 mg for those weighing less than 50 kg daily for the full 6 months. Usually 300 mg daily for the full 6
months.
-
Pyrazinamide (for the
first 2 months )
1.5 g. daily for those weighing less than 50 kg .
1.6 - 2.0 g. daily for those weighing between 50 and 74 kg. , and
1.7 - 2.5 g. daily for those over 75 kg in weight.
-
Ethambutol: for the
first 2 months (dosage 15 mg/kg body weight daily).
These drugs should be
given together.Another anti-tuberculous drug is usually given in
combination of these drugs.
Another regimen(adult
doses) for treatment of tuberculosis is :
Isoniazid 3oomg,
Rifampicines 600mg, Pyrazinamide 2gm and streptomycin 1gm or Ethambutol
15mg/kgm qd for 2 months followed by one of the following: Isoniazid 300mg
and rifampin 600mg qd for 4 months or Isoniazid 900mg,rifampin 600mg qd
for 4 months.
Para-amino salicylic
acid(PAS): is used only as concomitant therapy with INH or streptomycin.
Vaccination: a vaccine
containing polysaccharide prepared from a pure human-type tubercle
bacilli was tried for treatment of cutaneous tuberculosis with encouraging
results.
All drugs are taken on an
empty stomach once daily.
BCG
VACCINATION
Currently used strains,
maintained BCG (bacille Calmette-Guerin) vaccines owe their origin to the
in vitro attenuation by Calmette and Guerin.
Vaccination protects the
host by blocking the secondary hematogenous spread of the pathogen,
limiting the primary infection to subclinical proportions.
The protective effect of
BCG in children is likely to last at least 15 years.
High-risk groups, such as
hospital workers or travellers to areas of high prevalence are advised
for vaccination .
Fig. 35c.&d Exfoliative dermatitis
after B.C.G vaccination
The technique of
vaccination should be as follows :
The vaccine should be
reconstituted fresh for each session and given by intradermal injection
into the skin of the left upper arm in the sulcus over the insertion of
the left deltoid muscle.
A separate 1ml plastic
syringe and short bevel gauge 25 needle should be used for each patient .
The dose for infants is
0.05 ml , older children and adults are given double of this dose .
A local reaction usually
occurs 2 to 6 weeks after vaccination as a small papule that may slowly
enlarge and discharges purulent material to leave a shallow ulcer.
REFERENCES
-
Gracey DR.
Tuberculosis in the world today. Mayo Clin Proc 1988; 63: 1251-5.
-
Capewell S, France A,
Uzel N et al. The current value of tuberculin testing and
-
BCG vaccination in
children. Br J Dis Chest 1986; 80: 254-65.
-
Rieder HL, Cauthen
GM, Kelly GD et al. Tuberculosis in the United States. J
-
Am Med Assoc 1989;
262: 385-9.
-
Sehgal VN, Srivastava
MD, Khurana VK et al. An appraisal of epidemiologic,
-
clinical,
bacteriologic, histopathologic and immunologic parameters in cutaneous
-
tuberculosis. Int J
Dermatol 1987; 26: 521-6.
-
Grosset JH. Present
status of chemotherapy for tuberculosis. Rev Infect Dis 1989; 11
(Suppl. 2): 34752.
-
Goette DK, Jacobson
KW, Doty RD. Primary inoculation tuberculosis of the skin. Arch
Dermatol 1979; 114: 567-9.
-
Ramesh V, Misra RS,
Jain RK. Secondary tuberculosis of the skin: clinical features and
problems in laboratory diagnosis. Int J Dermatol 1987; 26: 578-81.
-
Kennedy C, Knowles
GK. Miliary tuberculosis presenting with skin lesions. BrMed J 1975;
3: 356.
-
Duhra P, Grattan CE,
Ryatt KS. Lupus vulgaris with numerous tubercle bacilli. Clin Exp
Dermatol 1988; 13: 31-3.
-
Ramesh V, Misra RS,
Jain RK. Secondary tuberculosis of the skin: clinical features and
problems in diagnosis. Int J Dermatol 1987; 26: 578-81.
- Voyce MA, Hunt AC. Congenital
tuberculosis. Arch Dis Child 1966; 41:299-300.
-
Hassoun PM. Erythema
induratum and active pulmonary tuberculosis. Am JMed 1988; 84: 784-5.
-
Grosset JH. Present
status of chemotherapy for tuberculosis. Rev Infect Dis1989; 11
(Suppl. 2): 347-52.
-
Sensi P. Approaches
to the development of new antituberculosis drugs. Rev Infect Dis 1989;
11 (Suppl. 2): 467-70.
- Maruyama, C.: Studies on treatment of
skin tuberculosis with extracts from tubercle
bacilli.Jap..J.Derm.(ser. B) 74:70-88(Jan.)1964.
Top
|